N-(5-Bromo-3-methylpyridin-2-yl)acetamide, 95.0%, 1g

(R)-3-N-Boc-Aminomethyl pyrrolidine, 98.0%, 5g

N,N-Dicyclohexylcarbodiimide (DCC), 100 g, >=98%, emballage en verre

4,4-Dimethyl-6-ethynylthiochroman, ?98.0%, 10g

2-Oxa-7-azaspiro[3.5]nonane oxalate(2:1), 95.0%, 1g

3-Methoxycarbonyl-5-nitrophenylboronic acid, 98.0%, 10g

methyl bicyclo[1.1.1]pentane-1-carboxylate, 97, 100mg

(R)-3-(3,4-dimethoxyphenoxy)pyrrolidine hydrochloride, 98%, 250mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-5,5,5-trifluoropentanoic acid, 98%, 250mg

6-Bromo-2-fluoro-3-iodobenzaldehyde, 97%, 5g

2-Bromo-4-(4-(trifluoromethyl)phenyl)thiazole, 95.0%, 1g

2-hydrazinylidene-5-(trifluoromethyl)-2,3-dihydro-1,3-benzothiazole, 97%, 1g